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Background/aim: The retinol level and retinol delivery to the placenta may vary depending on various factors involving the mother and
newborn. The present study evaluates the factors affecting retinol levels in newborns and the transplacental retinol passage in preterm
newborns.
Materials and methods: In this prospective cohort study, the retinol and retinol binding protein (RBP) in the umbilical cord blood of 44
preterm infants with a gestation age of <30 weeks were studied. Serum retinol and RBP levels were determined using an enzyme-linked
immunosorbent assay, and the rate of transplacental retinol passage was calculated. The demographic data of mothers and newborns,
the use of vitamins by the mother, the application of antenatal corticosteroids, and any diseases diagnosed during pregnancy were
recorded. An evaluation was made of the retinol, RBP, and other factors of the mother and newborn affecting transplacental retinol
passage.
Results: A retinol deficiency was identified in 68.2% of the study population. Retinol and RBP levels in umbilical cord blood (273.7 ±
150.03 ng/mL, 7.88 ± 5.6 ng/mL, respectively) were significantly higher than the corresponding levels in the mother (206.4 ± 86.26 ng/
mL, 1.04 ± 0.97 ng/mL, respectively). Umbilical cord blood retinol deficiency was more common in the male participants, while the
transplacental retinol passage rate was higher in females. The umbilical cord blood RBP was found to be lower in those administered
antenatal corticosteroids than in those who did not receive antenatal corticosteroids, and median maternal RBP levels were lower in
patients with anemia and pregnancy-induced hypertension than in those with no disease.
Conclusion: Placental adaptation and contributing factors may vary in populations with severe retinol deficiency. The finding of
significantly increased cord blood retinol levels when compared to maternal retinol levels in the present study suggests that some
compensatory mechanisms, such as increased placental RBP levels, support the presentation of retinol to the fetus, even if the mother
has a retinol deficiency.
Key words: Preterm infant, retinol, placenta

1. Introduction
Retinol is an essential vitamin that plays a role in the
expression of many genes and in the growth of the fetus.
Retinol plays a critical role in pregnancy with regard to
rapid cell division and growth [1,2]. Retinol is necessary
for the development of multi-organ systems, including the
immune system, lungs, eyes and thyroid [2,3]. According
to the World Health Organization (WHO) data, retinol
(vitamin A) deficiency (<0.7 mmol/L or <20 µg/dL) is a
significant public health problem with a considerable
contribution to mortality, especially in developing

countries (4). Malnourishment in pregnant women has
been reported to cause chronically low levels of maternal
retinol stores in countries with a low income levels [4].
Fetal retinol deficiencies can lead to many congenital
abnormalities, with links identified between embryonic
retinol deficiency and cleft lip/cleft palate, anophthalmia
or microphthalmia, urogenital system abnormalities,
abnormalities of the heart and large vessels, and extremity
malformations [5–7].
Retinol synthesizes de novo [8], starting in the early
intrauterine period, when the fetus is dependent on the
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mother’s retinol in whom it is stored in the liver and
released into the blood circulation together with the
retinol-binding protein (RBP), as a transport protein [8,9].
RBP is a protein with a 21 kDa weight that binds a single
retinol molecule, and that is involved in the transport of
retinol to peripheral tissues or the embryo [9–11]. The
retinol-RBP complex comprises 95%–99% of all retinoids
in circulation, and is present at a 1:1 molar rate [8,12]. The
retinol intake of the fetus is maintained at a stable level
through possible maternal hemostatic mechanisms, even
though fluctuations may occur in maternal retinol levels
[13]. The maternal retinol-RBP complex is separated in the
blood-placental barrier, creating free retinol that passes
through the placenta in maternity [10]. Maternal RBP has
been shown not to pass the placenta [8,10]. Fetal RBP is
produced in the yolk sac endoderm and in the placental
uterine intersection, starting in the early intrauterine
period [14], although fetal RBP does not pass into the
maternal circulation [10].
Preterm newborns are known to have lower serum
and hepatic retinol levels than term newborns [12,15],
although it has been reported that retinol deficiency is
more common in the mothers of newborns with low
serum retinol levels at birth [16]. Newborns have lower
capacity for hepatic retinol storage due to the low maternal
retinol levels during pregnancy and the selective bloodplacental barrier, and this also protects the fetus from the
possible teratogenic effect of retinol [17]. That said, data
is limited on the role of the placenta in the retinol intake
of mothers with retinol deficiency. Normal development
in the embryo has been demonstrated in animal models
in the absence of maternal RBP and in cases of sufficient
retinol intake [10], and in such cases, even though hepatic
storage is inadequate, the retinol intake in the diet has
been reported to be adequate for the development of the
fetus [10]. Placental retinol passage is known to increase
in cases of maternal retinol deficiency [18]. Placental
regulatory mechanisms might be effective in the transfer
of retinol, which is known to have a teratogenic effect
when deficient or present in excessive amounts [10,18,19].
In animal models, placental RBP has been shown to play a
key role in fetal retinol utility in cases of maternal retinol
deficiency [10].
This is the first study in Turkey to evaluate the factors
affecting maternal and umbilical cord blood retinol and
RBP levels, as well as the rate of transplacental retinol
passage in preterm newborns. Determining the retinol
levels and the associated factors in the pregnant population
in every country, and even in every region, is important for
public health.
The present study evaluates the factors affecting
umbilical cord blood and maternal retinol and RBP
levels, as well as transplacental retinol passage in preterm
newborns.

2. Materials and methods
This cohort study was conducted prospectively between
June 2020 and January 2021 in the Obstetrics and
Gynecology Clinics of Atatürk University. Ethics Board
approval was obtained from the Ethics Board of the
Medical School of Atatürk University (Decision no: 20207/29). Signed informed consent was obtained from the
families prior to patient selection.
2.1. Study population
Included in the study were preterms born in our hospital
at gestational week <30, while mothers or newborns with a
major abnormality or known congenital metabolic disease,
mothers with a chronic liver, kidney or gastrointestinal
system disease, and those who did not give consent were
excluded.
The sex and birth weight of the newborns, and the
gestation week, maternal age, gravidity, delivery mode,
vitamin intake, vitamin A use during pregnancy, and
antenatal steroid treatment in the mothers were recorded.
Also recorded were any preterm premature ruptures
of membranes (PPROM) diagnosed during pregnancy,
as well as preeclampsia/eclampsia, pregnancy-induced
hypertension, urinary infection, gestational diabetes
mellitus, and anemia, if present.
PROM refers to the rupture of membranes prior to
the onset of labor, while membrane ruptures before labor
and before 37 weeks of gestation is referred to as preterm
PROM [20].
Preeclampsia/eclampsia, and pregnancy-induced
hypertension were defined according to the diagnostic
criteria specified in the current American College of
Obstetricians and Gynecologists (ACOG) guidelines [21].
Those with at least one urine culture yielding a bacterial
growth of 105 colony-forming units/mL of urine during
pregnancy were recorded as having a urinary infection
[22].
Gestational diabetes mellitus is defined as glucose
intolerance diagnosed for the first time during pregnancy
based on fasting blood glucose or glucose tolerance tests
[23].
Anemia in pregnancy is defined as Hb <11 g/dL in the
first trimester, <10.5 g/dL in the second trimester and <11
g/dL in the third trimester [24].
2.2. Sampling and test study method
Approximately 6 ml of umbilical cord blood was drawn
at birth from all newborns included in the study by
experienced individuals using a vacutainer, and the same
amount of venous blood was drawn into a biochemistry
tube from the mothers’ antecubital region immediately
after birth, and centrifuged for 10 min at 4500 rpm after
the completion of coagulation, and the sera were separated.
The serum samples were frozen and stored at –80 ° until
the time of analysis, and were thawed in appropriate ways,
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with all analyses carried out in the Medical Biochemistry
Laboratory of Atatürk University at a single session.
The retinol levels of the serum samples were analyzed
using ELISA kits obtained from the Bioassay Technology
Laboratory (E1548 Hu Jiaxing, Zhejiang, China), RBP levels
were analyzed with ELISA kits provided by Elabscience
(E-EL-H1581 Texas, USA) following the standard
manufacturers protocol and using a Dynex automated
ELISA reading device (Dynex Technologies Headquarters,
Chantilly, USA). The measurement ranges of the kits for
retinol and RBP were 2–800 ng/mL and 0.07–100 ng/mL,
respectively. Both intra- coefficient variability and intercoefficient variability are < 10%.
The formula “umbilical cord blood retinol/maternal
retinol x100” was used to calculate the placental retinol
passage rate, identifying the percentage of maternal retinol
passing into the umbilical cord blood [18].
Retinol deficiency was evaluated based on WHO
guidelines [4], with a level of <20 µg/dL accepted as a
deficiency. A deficiency level of <200 ng/mL was accepted
to match the ng/mL unit adopted in the present study.
2.3. Statistical analysis
The statistical analysis was carried out using IBM SPSS
Statistics v. 23.0 (IBM Corp., Armonk, NY, USA).
Descriptive statistics were applied for distributions
(number and percentage), and numerical properties for
numerical data (mean, median, std. deviation, minimum
and maximum). Shapiro–Wilk and Kolmogorov–Smirnov
tests were used to analyze the normality of the distribution.
G-power software (v. 3.1.9.2, Kiel, Germany) was used
to determine the sample size. The number of patients
required was determined 42 for t-test analysis of newborns
and mother’s groups with 0.55 effect size, 5% type I error,
and 80% power. Parametric tests were used to compare
maternal retinol and RBP, and umbilical cord blood retinol
and RBP levels and the groups with normal distribution
of these levels (sex, gravidity, antenatal corticosteroids).
Nonparametric tests were used to compare retinol and RBP
levels in maternal disease groups. A t-test was used for the
comparison of parametric tests, the Mann–Whitney U test
for the comparison of two groups, and the Kruskall–Wallis
test for the comparison of nonparametric data in more
than two groups. Pair-wise comparisons were performed
using Dunn’s post-hoc test. A Pearson correlation test was
used to evaluate whether the continuous variables were
correlated. A Chi-square test was used for the comparison
of categorical variables with each other. A two-tailed
p-value of <0.05 was accepted as significant.
3. Results
During the study period, 76 newborns under 30 weeks’
gestation were born at our hospital, and 44 of these
premature newborns who met the inclusion criteria and
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whose family provided consent were included in the study.
Of these, 22 (50%) preterms were female and 22 (50%)
were male. The median age of gestation and birth weight
were 27.8 ± 2 weeks and 1007 ± 300 g, respectively. The
maternal mean age was 26.9 ± 6.5 years and the mothers’
pregnancies were numbered between 1 and 9. Among
the mothers, 16 were primiparous (36%) and 28 were
multiparous (64%). There was no multiple pregnancy
(twins or more) in our study. Three (6.8%) newborns
were delivered vaginally. All 41 (93.2%) mothers who had
cesarean delivery were administered general anesthesia.
Only 3 (6.8%) mothers used vitamins (folic acid and/or
multivitamins) for 30–45 days during pregnancy. None of
the mothers received additional vitamin A supplements.
Among the mothers, 26 were administered antenatal
corticosteroids (59%) while 18 were not (41%).
The mean maternal retinol and RBP level was 206.4
± 86.2 ng/mL and 1.04 ± 0.97 ng/mL, respectively,
and the mean umbilical cord blood retinol and RBP
levels were 273.7 ± 150 ng/mL and 7.88 ± 5.6 ng/mL,
respectively. Umbilical cord blood retinol levels and RBP
were statistically significantly higher than the respective
maternal levels (p: <0.001 and p: 0.007, respectively)
(Table 1). A positive correlation was identified between
the maternal and umbilical cord blood retinol levels (r:
0.42, p: 0.04), while no correlation was found between the
umbilical cord blood RBP and the maternal RBP levels (r:
0.07, p: 0.65). The rate of retinol deficiency (<200 ng/mL)
was found to be higher in the maternal blood (30, 68.2%)
than in the umbilical cord blood (18, 40.9%) (p < 0.001).
No associations were identified between the maternal
and umbilical cord blood retinol and RBP levels, nor the
birth weight, gestational week or maternal age (Table 2).
No effects of gestational week, birth weight and maternal
age were identified in the presence of retinol deficiency in
the umbilical cord blood or in maternal samples (Table
3), and no significant difference was found between sex
and the maternal and umbilical cord blood retinol RBP
levels (Table 4). However, when the distribution of retinol

Table 1. Comparison of retinol and RBP values studied in
maternal and cord blood.
Mean (ng/mL)
Cord blood retinol

≠

273.7 ± 150

Maternal retinol ≠

206.4 ± 86.2≠

Cord blood RBP*, ≠

7.88 ± 5.6

Maternal RBP*,≠

1.04 ± 0.97

*RBP: Retinol binding protein.
≠ mean ± standard deviation.

P
<0.001
0.007
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Table 2. Correlations between retinol and RBP levels and demographic data.
UCB* retinol

Maternal retinol

UCB* RBP***

Maternal RBP***

R **

P

R **

P

R **

P

R **

P

Gestational age

- 0.09

0.52

- 0.01

0.92

0.03

0.81

0.01

0.91

Birth weight

- 0.06

0.67

0.08

0.57

- 0.15

0.37

0.11

0.45

Maternal age

- 0.15

0.32

- 0.12

0.42

0.04

0.79

0.2

0.19

*UCB: Umbilical cord blood.
**R: Correlation coefficient.
***RBP: Retinol binding protein.
Table 3. Comparison of groups according to the umbilical cord blood and maternal retinol deficiency.
UCB* retinol
UCB* retinoldeficiency (n = 18) normal (n = 26)

P*

Maternal retinol
Maternal retinolP*
deficiency (n = 30) normal (n = 14)

Gestational age (week) ≠

28.3 ± 1.7

27.5 ± 2.1

0.16

27.9 ± 2.1

27.6 ± 1.7

0.63

Birth weight (g) ≠

1050 ± 262

977 ± 326

0.43

1002 ± 328

1015 ± 241

0.89

29.3 ± 7

27.5 ± 5.7

0.06

26.9 ± 7

26.8 ± 5.6

0.97

Female
(n = 22)

5 (22.7%)

17 (77.3%)

16 (72.7%)

6 (27.3 %)

Male
(n = 22)

13 (54.5%)

9 (45.5%)

14 (63.6%)

8 (36.4 %)

Primiparous
(n = 16)

4 (25%)

12 (75 %)

10 (62.5)

6 (37.5 %)

Multiparous
(n = 28)

14 (50%)

14 (50 %)

20 (71.4%)

8 (28.6 %)

None
(n = 18)

8 (44.4%)

10 (55.6 %)

13 (72.2%)

5 (27.8 %)

10 (38.4%)

16 (61.6 %)

17 (65.3%)

9 (34.7 %)

None
(n = 20)

7 (35%)

13 (65 %)

12 (60%)

8 (40 %)

Present
(n = 24)

11 (45.8%)

Maternal age (year)

Sex

€

Gravidity

€

≠

Antenatal
corticosteroids € Present
(n = 26)
Maternal
disease €

0.03

0.74

0.12

0.73

0.76

0.74

0.54
13 (54.2 %)

0.34
18 (75%)

6 (25 %)

* UCB: Umbilical cord blood.
≠ mean ± standard deviation.
€ number (%).

deficiency was evaluated, umbilical cord blood retinol
deficiencies were identified in 12 of the 22 (54.5%) male
newborns and five of the 22 (22.7%) female newborns.
Umbilical cord blood retinol deficiencies were found to
be significantly more common among the male newborns
than the female newborns (p: 0.03) (Table 3).
In this study group, the umbilical cord blood and
maternal retinol levels in mothers who had received

vitamins were similar to those of the mothers who received
no vitamin supplements (p:0.23 and p:0.22 respectively).
No statistical analysis was made of this group to evaluate
any deficiencies, since vitamin use was limited and
the duration of vitamin intake was short (30–45 days).
Statistical analysis could also not be made of the mode of
delivery and the method of anesthesia, since there were
only three patients delivered vaginally and all mothers
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Table 4. Comparison of mean maternal and umbilical cord blood retinol and mean RBP with sex, gravidity, antenatal corticosteroids
use, and maternal diseases.
UCB* retinol
(ng/mL)
Sex ≠
Gravidity ≠
Corticosteroids ≠

Maternal
diseaseα

P

Maternal retinol
P
(ng/mL)

UCB* RBP**
(ng/mL)

203.1 ± 93.76

9.1 ± 7.2

P

Maternal RBP**
P
(ng/mL)

Female

303.1 ± 184

Male

244.3 ± 102.1

Primiparous

272.5 ± 151.6

Multiparous

274.4 ± 152.1

None

260.1 ± 145.6

Present

283.1 ± 155.1

None

209 (147-746)

182 (124–441)

6.8(0.87–13.8)

0.99 (0.05–

Preeclampsia

195 (176-680)

182 (137–297)

8.2 (2.6–6.3)

0.52 (0.21–3.44)

PPROMβ

265 (190-421)

207 (144–249)

6.5 (1.5–8.3)

Hypertension

206 (183–663)

0.2
0.96
0.62

0.55

209.8 ± 80.1
196.8 ± 52.6
212 ± 101
190.3 ± 56.4
217.6 ± 101.5

159 (123–496)

0.79
0.58
0.3

0.71

6.6 ± 3.1
8.35 ± 3.5
7.6 ± 6.6
10.6 ± 7.3
5.9 ± 3

6.2 (0.7–8.3)

0.14
0.68
0.006

0.1

0.81 ± 0.54
1.29 ± 1.24
1.17 ± 1.15
0.98 ± 0.86
1.13 ± 1.09
1.01

0.86

0.56 (0.16–1.21)
0.51 (0.21–1.3)

Urinary infection 191 (187-231)

175 (124–181)

12.7 (8.7–37.8)

1.32 (1.07–4.2)

Anemia

180 (141-218)

10.8 (9.2-12.4)

0.11 (0.02-0.21)

439 (261-617)

0.11
0.55
0.79

0.02

* UCB: Umbilical cord blood.
** RBP: Retinol binding protein.
≠ mean ± standard deviation.
α median (range).
β PPROM, preterm premature rupture of membranes.

undergoing cesarean section were administered general
anesthesia.
An analysis of the mothers who had been administered
antenatal corticosteroids and those who were not revealed
mean umbilical cord blood RBP levels of 5.9 ± 3.07 ng/mL
and 10.6 ± 7.3 ng/mL, respectively, being was significantly
lower in the group administered corticosteroids (p:0.006)
(Table 4). No difference was found in the frequency of
maternal and umbilical cord blood retinol deficiencies
among those with and without antenatal steroid application
(Table 3).
No accompanying disorder was identified in 20 of the
mothers (45%), while preeclampsia was present in 9 (20%),
PPROM in 4 (9%), pregnancy-induced hypertension in
6 (13.6%), urinary infection in 3 (6.8%), and anemia in
2 (4.5%). When the comparison between the umbilical
cord blood retinol-RBP and maternal retinol-RBP levels
in those diseases was evaluated, maternal RBP levels
were found to differ in different maternal diseases, to
a statistically significant degree (p:0.02) (Table 4). In
a subgroup analysis, the median maternal RBPs were
found to be 0.99 ng/mL (0.05–24.9 ng/mL), 0.51 ng/mL
(0.21–1.30 ng/mL) and 0.11 ng/mL (0.02–0.21 ng/mL) in
mothers with no accompanying disease, with pregnancyinduced hypertension and with anemia, respectively.
Maternal RBP levels were found to be lower in the
hypertension and anemia groups than in mothers with no
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additional disease (p: 0.04 and p: 0.01 respectively) (Table
4). In terms of the frequency of maternal and umbilical
cord blood retinol deficiency, the two groups with and
without additional diseases were compared, revealing no
significant differences (Table 3).
The mean rate of transplacental retinol passage was
134.1 ± 43.5%. A negative correlation was identified
between maternal RBP levels and transplacental passage
rate (r: –0.38, p: 0.01). In contrast, no correlation was
found between umbilical cord blood RBP levels and the
transplacental passage rate (r: 0.25, p: 0.09), although
the mean transplacental passage rate was 148.4 ± 46.8%
and 119.7 ± 35.4 % in the female and male newborns,
respectively, being significantly higher in the female group
(p:0.02). (Table 5).
4. Discussion
The detection of retinol deficiency in more than 20% of
a society is a serious public health problem, according
to WHO criteria [4]. In the present study group, retinol
deficiencies were present in 68.2% of mothers and in
40.9% of preterm infants, indicating a severe retinol
deficiency in the study group. The maternal/fetal retinol
concentration is around 2:1 in mothers in the absence of
severe retinol deficiency [15]. Low retinol levels in the
newborns of mothers with retinol deficiency have been
reported, and there are also reports of transplacental
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Table 5. Comparison of transplacental retinol passage.
Transplacental
retinol passage (%)
Sex ≠
Gravidity ≠
Antenatal corticosteroids ≠
Maternal disease ≠

Female

148.4 ± 46.8

Male

119.7 ± 35.4

Primiparous

139 ± 58.3

Multiparous

130 ± 33

None

138.2 ± 54.6

Present

131.2 ± 34.7

None

121.9 ± 41.1

Present

144.2 ± 43.7

P
0.02
0.5
0.6
0.09

≠ mean ± standard deviation.

retinol passage being increased in this group [18,25].
A positive correlation was found in the present study
between maternal and cord blood retinol levels. It is
worthy of note, however, that umbilical cord blood retinol
levels were statistically significantly higher than maternal
retinol levels. The vitamin A metabolism and its placental
organization is a complex process, and there are some as
yet unknown mechanisms [13,15]. These results suggest
that fetus-preserving placental homeostatic mechanisms
are effective even in the case of severe retinol deficiency
in mothers, and that the recommended daily vitamin
A intake in diet may be sufficient, as mentioned in the
animal model study by Quadro et al. [10]. Nevertheless,
in literature, fetal vitamin A levels are reported to be
relatively stable, despite fluctuations in maternal retinol
levels [26]. None of the patients in the present study had
teratogenicity related to retinol deficiency.
In the present study, cord blood RBP levels were also
markedly higher than the maternal RBP levels, indicating
increased placental RBP in mothers with retinol deficiency.
Placental homeostasis has plays a key role in the delivery
of retinol to the fetus, and is responsible for the storage
of retinoids until the fetal liver maturation is complete
[27,28]. It has been further reported that the homeostatic
mechanisms that affect maternal RBP levels are also
effective in retinol delivery to the fetus [26]. In the present
study, a negative correlation was identified between
maternal RBP levels and transplacental retinol transfer. It
is possible that maternal RBP levels, and in turn, placental
retinol delivery, is decreased due to the increased passage
of transplacental retinol to protect the fetus from a sudden
increase in retinol levels.
Serum retinol levels are lower in preterm newborns than
in full-term newborns [29–32], although contradictory
findings have been reported regarding the effects of
gestational week on serum retinol levels in premature

newborns [16,33–35]. In their autopsy study, Shenai et al.
evaluated 25 newborns with extremely low birth weight
(ELBW) and reported no difference in serum and hepatic
vitamin A levels, based on sex, race, gestational week
and birth weight [33]. Tao et al. reported no association
between <35 weeks’ gestational age and < 2500 g birth
weight with umbilical cord blood vitamin A deficiency
(< 0.7 mmol/L) [34]. Conversely, there have been studies
reporting lower serum vitamin A levels in the male sex
than in the female sex in literature [36–38]. In the present
study, no association was found between the maternal and
umbilical cord blood retinol levels and sex, birth weight,
gestational week, maternal age or gravidity, while the
frequency of umbilical cord blood retinol deficiency was
significantly higher in male newborns when compared to
female newborns. We also found transplacental retinol
passage to be higher in the female sex when compared
to the male sex. The lesser frequency of umbilical cord
blood retinol deficiency in females might be attributed
to this finding. Nevertheless, there is a lack of adequate
data explaining how the placental vitamin A metabolism
changes based on the fetal sex.
Different results have been reported on the effect of
antenatal corticosteroids on umbilical cord blood retinol
levels [39,40]. Inder et al., in their study evaluating
the association of retinol levels in the newborn and
respiratory outcome in 57 newborns with extremely low
birth weights, reported that antenatal steroid application
increased the umbilical cord blood retinol level [39]. Chen
et al. reported that antenatal steroid applications had no
effect on the frequency of serum retinol deficiency (<20
µg/dL) in samples taken within the first 48 h of birth in
their study of 115 premature newborns at <29 weeks of
gestation and/or <1250 g birth weight [40]. In the present
study, umbilical cord blood retinol, and maternal retinol
and RBP levels were found to be higher in the group
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treated with antenatal corticosteroids than in those who
were not, although not significantly. In addition, it was
determined that antenatal corticosteroids had no effect
on the transplacental passage rate of retinol. In contrast,
umbilical cord blood RBP levels in the present study was
statistically significantly lower in the group administered
antenatal corticosteroids than in those not treated with
antenatal corticosteroids. It has been reported in literature
that maternal and umbilical cord blood RBP levels increase
with the administration of antenatal corticosteroids
[41,42], although simultaneous retinol levels were not
investigated in those studies, and so no data was provided
on how antenatal corticosteroids could affect umbilical
cord blood RBP levels in the presence of retinol deficiency
[41,42]. Georgieff et al. reported the potential of RBP
synthesis to be increased in newborns due to the additive
effect of antenatal corticosteroids on hepatic maturation
[42]. The role of placental RBP in the retinol metabolism
of preterm newborns has been well documented [10,14].
We suggest that antenatal corticosteroids could affect
placental homeostasis differently in situations in which
maternal retinol deficiency is more frequent, as seen
especially in our study population.
Retinol deficiency in the mother may have some
negative consequences during pregnancy. In Cochrane’s
meta-analysis, it was reported that vitamin A intake, along
with iron and folic acid supplementation, may decrease
the incidence of anemia in pregnancy in mothers with
vitamin A deficiency [43]. Radhika et al. reported vitamin
A deficiency in mothers to increase the rate of anemia
[44], while there have been reports on preeclampsia stating
that maternal RBP levels have decreased, increased or
remained unchanged [45–47]. It has been further reported
that maternal RBP associated with gestational diabetes
and increased RBP is a marker of insulin resistance [48].
Inoue et al. found that maternal RBP levels increased
and umbilical cord blood RBP levels decreased in the
presence of pregnancy-induced hypertension, and it has
been reported that this condition may be attributable
to insulin resistance in the mother [49]. No association
has been found between preeclampsia, urinary infection
and PPROM, and maternal-umbilical cord blood retinol
and RBP levels. Maternal RBP levels were found to be
lower in patients with pregnancy-induced hypertension
and anemia than in those with no additional disease.
Hypertension and anemia can have multiple causes, such
as malnutrition during pregnancy [50,51]. In the present
study, the significantly low levels of retinol in this patient
population indirectly suggested malnutrition in the study
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population, and the low levels of maternal RBP in the
study among patients with hypertension and anemia may
also be due to malnutrition.
This study has some limitations. The high rate of retinol
deficiency in our region was an unforeseen condition,
and therefore, risk factors such as maternal nutrition
were not considered as a cause of retinol deficiency. In
addition, due to the COVID-19 pandemic, the number
of patients recruited was lower than expected, the study
having been planned prior to the pandemic. The numbers
were small, particularly in some patient groups, in order
to evaluate the effects of maternal diseases on retinol
metabolism. Besides, the effect of the mode of delivery and
the method of anesthesia could not be evaluated in those
who had cesarean delivery Finally, the effect of placental
insufficiency on retinol metabolism was not studied, as
placental insufficiency was not evaluated.
In conclusion, placental retinol passage is regulated
according to the presence of a maternal deficiency of retinol.
Retinol is essential for the fetus, while excessive amounts
are undesirable, and different factors affect its levels in
various populations. Significantly high umbilical cord
blood retinol and RBP levels when compared to maternal
retinol and RBP levels, as was the case in some cases in the
present study, suggest that some of the known factors that
affect the transplacental retinol passage could be adjusted
in populations with maternal retinol deficiencies. That said,
studies of the placental compensation in cases of retinol
deficiency involving larger populations are required.
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